1. Home
  2. RENB

as 09-17-2025 2:35pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Founded: 2011 Country:
United States
United States
Employees: N/A City: SUITE 906 LOS ANGELES
Market Cap: 57.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 993.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.38 EPS Growth: N/A
52 Week Low/High: $0.17 - $2.10 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

RENB Daily Stock ML Predictions

Share on Social Networks: